Cargando…
SEOM-GEICO clinical guidelines on endometrial cancer (2021)
Endometrial cancer (EC) is the second most common gynecological malignancy worldwide, the first in developed countries [Sung et al. in CA Cancer J Clin 71:209–249, 2021]. Although a majority is diagnosed at an early stage with a low risk of relapse, an important proportion of patients will relapse....
Autores principales: | Barretina-Ginesta, María Pilar, Quindós, María, Alarcón, Jesús Damián, Esteban, Carmen, Gaba, Lydia, Gómez, César, Fidalgo, José Alejandro Pérez, Romero, Ignacio, Santaballa, Ana, Rubio-Pérez, María Jesús |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986694/ https://www.ncbi.nlm.nih.gov/pubmed/35312947 http://dx.doi.org/10.1007/s12094-022-02799-7 |
Ejemplares similares
-
SEOM clinical guideline in ovarian cancer (2020)
por: Redondo, A., et al.
Publicado: (2021) -
SEOM clinical guidelines for endometrial cancer (2017)
por: Santaballa, A., et al.
Publicado: (2017) -
SEOM clinical guidelines for the prophylaxis of infectious diseases in cancer patients (2021)
por: Echavarria, Isabel, et al.
Publicado: (2022) -
Efficacy and safety of trabectedin in metastatic uterine leiomyosarcoma: A retrospective multicenter study of the Spanish ovarian cancer research group (GEICO)
por: Rubio, María Jesús, et al.
Publicado: (2020) -
SEOM Clinical Guideline in ovarian cancer (2016)
por: Santaballa, A., et al.
Publicado: (2016)